Almac Group
Almac is a pharmaceutical service provider with over 30 years experience. The company provides a range of services including research and development, pharmaceutical testing and clinical trials as well as the commercialisation of pharmaceutical products. The company has experience in biomarker discovery and development through its partners and through internal R&D.
Almac provides comprehensive support from drug discovery through to scale-up and launch of new drugs. Pharmaceutical development includes pre-formulation of drugs, testing and taking them to market. The company has three chemical trial sites globally, with one in Northern Ireland situated at Craigavon.
The company also specialises in the design and manufacture of drug packaging including blistering, bottling and walleting/carding of pharmaceuticals.
Financial Data
-
30th Sep 19 Source: CRO
- €742.8 million turnover
-
€55.8 million
profit - 5,150 employees
-
30th Sep 18 Source: CRO
- €619.3 million turnover
-
€31.2 million
profit - 4,978 employees
- 11 more years available »
Ranking
By Turnover
(€742.8 million)- 123rd in Top Companies
- 19th in Health
By Employees
(5,150)- 43rd in Top Companies
- 6th in Health
-
- 5,150
- €742.8 million
Employees
- Alan Armstrong CEO/Managing Director
Latest News
- 1:13pm Home computing pioneer Clive Sinclair dies
- 1:00pm Global growth and Evergrande worries dampen stocks
- 12:54pm Inflation fears ‘overstated’, Central Bank governor says
- 12:03pm Unpublished ECB inflation estimate raises prospect of earlier rate rise
- 10:00am Beijing applies to join Asia-Pacific trade pact